The signature of the real Mukai extension, from the signature of V #
PeriodDomain.HasSignatureTwo has been a hypothesis everywhere in route (A).
For the Mukai extension it should be a consequence: ℝ × V × ℝ is a hyperbolic
plane orthogonal to V, the plane contributes (1, 1), and the rest is V's
own signature. With V = NS(X) ⊗ ℝ that reduces the hypothesis to the Hodge
index theorem, which is where it should rest.
This is step 2 of the additivity work; step 1 is
QuadraticForm/SignatureAdditive.lean.
Shape of the argument #
The two summands are the ranges of the obvious inclusions rather than
Submodule.prods. That is not cosmetic: a range comes with
LinearEquiv.ofInjective, which is exactly the isometry needed to transport a
signature computation from ℝ × ℝ and from V into the summand, and it gives
the dimension count for free.
The plane's own signature is pinned by two explicit lines — (1, -1) is
positive, (1, 1) is negative — plus the counting identity, which forces
sigPos = sigNeg = 1 and leaves no radical.
Convention, restated because it is load-bearing #
realForm b is half the self-pairing (Mukai/RealForm.lean), so on the
plane it is (r, s) ↦ -r * s, and on the middle summand it is c ↦ b c c / 2.
Halving does not move definite subspaces, which is sigPos_smul_of_pos below,
so V's signature transports unchanged.
The restriction of a form to the range of an injective map is the form pulled back along that map. This is what makes a range-shaped summand cheap to compute with.
Equations
- QuadraticMap.rangeIsometry Q f hf = { toLinearEquiv := LinearEquiv.ofInjective f hf, map_app' := ⋯ }
Instances For
A positive scalar does not move the positive definite subspaces.
The inclusion of the middle summand {(0, c, 0)}.
Instances For
The hyperbolic plane summand.
Equations
Instances For
The signature of the real Mukai extension, from the signature of V.
With V = NS(X) ⊗ ℝ the hypotheses are the Hodge index theorem, so the
signature condition every period-domain result carries stops being an assumption
about the Mukai lattice.